Literature DB >> 31240332

Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study.

Serine Sahakyan1, Varduhi Petrosyan2, Lusine Abrahamyan2,3,4.   

Abstract

OBJECTIVES: This study aimed to investigate the impact of diabetes on the treatment outcomes among pulmonary TB patients in Yerevan, Armenia.
METHODS: We utilized a cohort study design that included TB patients with diabetes and TB patients without diabetes. The data collection was conducted in the National Tuberculosis Control Center, eight tuberculosis outpatient centers and the 'Prisoners' Hospital' in Yerevan, Armenia. Data were collected from an existing national TB database and patients medical records. Multivariable logistic regressions were conducted to construct the final model and test the associations.
RESULTS: The final sample included 621 patients 5.8% of whom had diabetes. The odds of having treatment failure was 8.99 times higher among TB patients with diabetes (95% confidence interval 2.51-32.23) compared to TB patients without diabetes after adjusting for weight and sputum smear status.
CONCLUSIONS: Diabetes comorbidity had a negative effect on TB treatment outcomes. Countries with a high burden of both TB and diabetes need to develop mechanisms for active screening for diabetes among patients with TB and address their treatment needs carefully.

Entities:  

Keywords:  Cohort study; Diabetes; Treatment failure; Tuberculosis

Mesh:

Year:  2019        PMID: 31240332     DOI: 10.1007/s00038-019-01277-2

Source DB:  PubMed          Journal:  Int J Public Health        ISSN: 1661-8556            Impact factor:   3.380


  23 in total

1.  Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.

Authors:  Hanneke M J Nijland; Rovina Ruslami; Janneke E Stalenhoef; Erni J Nelwan; Bachti Alisjahbana; Ron H H Nelwan; Andre J A M van der Ven; Halim Danusantoso; Rob E Aarnoutse; Reinout van Crevel
Journal:  Clin Infect Dis       Date:  2006-08-22       Impact factor: 9.079

2.  In search of patient-centred care in middle income countries: the experience of diabetes care in the former Soviet Union.

Authors:  Charlotte Kühlbrandt; Dina Balabanova; Ivdity Chikovani; Varduhi Petrosyan; Kseniya Kizilova; Oksana Ivaniuto; Olga Danii; Noune Makarova; Martin McKee
Journal:  Health Policy       Date:  2014-08-30       Impact factor: 2.980

3.  Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000.

Authors:  T Santha; R Garg; T R Frieden; V Chandrasekaran; R Subramani; P G Gopi; N Selvakumar; S Ganapathy; N Charles; J Rajamma; P R Narayanan
Journal:  Int J Tuberc Lung Dis       Date:  2002-09       Impact factor: 2.373

4.  Type 2 diabetes and pneumonia outcomes: a population-based cohort study.

Authors:  Jette B Kornum; Reimar W Thomsen; Anders Riis; Hans-Henrik Lervang; Henrik C Schønheyder; Henrik T Sørensen
Journal:  Diabetes Care       Date:  2007-06-26       Impact factor: 19.112

5.  Working-age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study.

Authors:  Darren Lau; Dean T Eurich; Sumit R Majumdar; Alan Katz; Jeffrey A Johnson
Journal:  Diabetologia       Date:  2014-02-06       Impact factor: 10.122

6.  Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam.

Authors:  H T Quy; F G J Cobelens; N T N Lan; T N Buu; C S B Lambregts; M W Borgdorff
Journal:  Int J Tuberc Lung Dis       Date:  2006-01       Impact factor: 2.373

7.  Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014.

Authors:  Cintia Muñoz-Quiles; Mónica López-Lacort; F Javier Ampudia-Blasco; Javier Díez-Domingo
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

8.  Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes.

Authors:  María Eugenia Jiménez-Corona; Luis Pablo Cruz-Hervert; Lourdes García-García; Leticia Ferreyra-Reyes; Guadalupe Delgado-Sánchez; Miriam Bobadilla-Del-Valle; Sergio Canizales-Quintero; Elizabeth Ferreira-Guerrero; Renata Báez-Saldaña; Norma Téllez-Vázquez; Rogelio Montero-Campos; Norma Mongua-Rodriguez; Rosa Areli Martínez-Gamboa; José Sifuentes-Osornio; Alfredo Ponce-de-León
Journal:  Thorax       Date:  2012-12-18       Impact factor: 9.102

Review 9.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

10.  Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients.

Authors:  M Martins; J M Boavida; J F Raposo; F Froes; B Nunes; R T Ribeiro; M P Macedo; C Penha-Gonçalves
Journal:  BMJ Open Diabetes Res Care       Date:  2016-05-20
View more
  2 in total

1.  Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013-2017.

Authors:  Sherali Massavirov; Kristina Akopyan; Fazlkhan Abdugapparov; Ana Ciobanu; Arax Hovhanessyan; Mavluda Khodjaeva; Jamshid Gadoev; Nargiza Parpieva
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

2.  Factors Influencing Treatment Adherence Among Drug-Sensitive Tuberculosis (DS-TB) Patients in Armenia: A Qualitative Study.

Authors:  Zaruhi Grigoryan; Robert McPherson; Tsovinar Harutyunyan; Nune Truzyan; Serine Sahakyan
Journal:  Patient Prefer Adherence       Date:  2022-09-01       Impact factor: 2.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.